Archives of Ophthalmology · 1978 · 327 citations · 2 references
MedicineOphthalmologyPharmacologyClinical OptometryOcular PharmacologyPharmacodynamicsMedication Effects On VisionOcular PharmacodynamicsRetinal PharmacotherapyTopical Ophthalmic MedicationsVasoactive MedicationsAdrenergic SignalingAqueous Outflow ResistanceBeta-adrenergic Blocker UseIntraocular Pressure ReductionIntraocular Pressure-lowering MechanismsOcular Hypertension TreatmentPlacebo-controlled Efficacy AssessmentSubjects
A single‑drop, double‑masked, randomized, placebo‑controlled study in 23 normal subjects used fluorophotometry to investigate how timolol maleate lowers intraocular pressure. Timolol reduced aqueous humor production by 13–48 % (mean 34 ± 9 %) in all subjects, with no impact on anterior chamber volume, endothelial permeability, outflow resistance, or differences by sex or iris color.
• A single-drop, double-masked, randomized, placebo-controlled study of the mechanism of the ocular-pressure lowering property of timolol maleate, a β-adrenergic blocker, was carried out in 23 normal subjects, using fluorophotometry. Timolol suppressed aqueous formation in all subjects. The range of suppression was 13% to 48%, with a mean ± SD of 34% ± 9%. The drug had no effect on anterior chamber volume or endothelial permeability to fluorescein and, apparently, had no effect on outflow resistance. No differences were observed between its effect on men and women or between eyes with light and dark irides.
2
Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.
Irving M. Katz, W A Hubbard, Albert J. Getson et al. · PubMed · 1976 · 183 citations